Skip to content
2000
Volume 1, Issue 1
  • ISSN: 1574-891X
  • E-ISSN: 2212-4071

Abstract

Tuberculosis (TB) is an important public health problem worldwilde due to AIDS epidemic, the advent of multidrug resistant strains (MDR) and the lack of new drugs in the market. TB is responsible for almost 3 millions deaths each year. According to WHO (World Health Organization), which declared tuberculosis a global health emergency in 1993, tuberculosis, without a coordinated control effort, will infect an estimated 1 billion people by 2020, killing 70 million. In spite of this problem, there is a lack of development of new TB drugs. For example, it has been nearly 35 years since the introduction of a new class of compounds for the treatment of TB. Thus, there is an urgent need for new drugs to fight against this disease. Considering that, this review aims promising drug candidates that are in development against TB.

Loading

Article metrics loading...

/content/journals/pri/10.2174/157489106775244163
2006-01-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/pri/10.2174/157489106775244163
Loading

  • Article Type:
    Research Article
Keyword(s): antimycobacterial activity; drugs; Tuberculosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test